Résultats de la recherche - 5 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
last PSV dose). We measured VE overall, by vaccine category/product, age group and time since first mRNA booster dose, adjusting by site as a fixed effect, and by swab date, age, sex, and ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
the Alpha period, VE against hospitalisation with SARS-CoV2 for complete Comirnaty PSV was 85% (95% CI: 69-92) overall and 75% (95% CI: 42-90) in those aged ≥ 80 years. During the Delta period, among ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Joana Gomes Dias; Sonja J Olsen Source: Euro Surveill, Volume 28, Issue 4 (2023) Keywords: Aged Antiviral Agents Enzyme Inhibitors Guanidines Hospital Mortality Humans Influenza, Human Neuraminidase ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
admitted to hospital with seasonal hCoV infections by age group. Samples received from week 8, 2020, were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Findings: 2573 primary care ...
Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.
Steven Van Gucht; Isabelle Thomas; Cyril Barbezange Source: Euro Surveill, Volume 25, Issue 39 (2020) Keywords: ADOLESCENT Adult Aged Belgium Child Child, Preschool Female Fever Hospitalization Humans ...